Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/214106
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation

AutorSantos-García, Diego; Jesús Maestre, Silvia CSIC ORCID; Aguilar Barberá, Miquel; Planellas, Lluís; García Caldentey, Juan; Caballol, Nuria; Legarda, Inés; Hernández-Vara, Jorge; Cabo-Lopez, Iria; López-Manzanares, Lydia; González-Aramburu, Isabel; Ávila-Rivera, María A.; Catalán, M. J.; López-Díaz, Luis M.; Puente, Víctor; García Moreno, J. M.; Borrué, Carmen; Solano Vila, Berta; Álvarez-Sauco, María; Vela-Desojo, Lydia; Escalante, Sonia; Cubo, Esther; Carrillo Padilla, Francisco; Martínez-Castrillo, J. C.; Sánchez Alonso, Pilar; Alonso Losada, María G.; López-Ariztegui, Nuria; Gastón, Itziar; Kulisevsky, Jaime; Menéndez-González, Manuel; Seijo-Martínez, Manuel; Ruiz Martínez, Javier; Valero, Caridad; Kurtis, Mónica; Fábregues-Boixar, Oriol de; González Ardura, Jessica; Prieto Jurczynska, C.; Martínez-Martín, Pablo; Mir, Pablo CSIC ORCID
Palabras claveGait
Mood
Motor fluctuations
Non‐motor symptoms
Parkinson's disease
Quality of life
Fecha de publicaciónnov-2019
EditorJohn Wiley & Sons
CitaciónEuropean Journal of Neurology 26(11): 1399-1407 (2019)
Resumen[Background and purpose]: In Parkinson's disease (PD ), the course of the disorder is highly variable between patients. Well‐designed, prospective studies for identifying PD progression biomarkers are necessary. Our aim was to show the results of baseline evaluations of an ongoing global PD project, COPPADIS ‐2015 (Co hort of Patients with PA rkinson's DI sease in Spain, 2015).
[Methods]: This was an observational, descriptive, nationwide study (Spain). The recruitment period ended in October 2017. Baseline evaluation included more than 15 validated scales and complementary studies in a subgroup of participants.
[Results]: In total, 1174 subjects from 35 centres were considered valid for baseline analysis: 694 patients (62.6 ± 8.9 years old, 60.3% males), 273 caregivers (58.5 ± 11.9 years old, 31.8% males) and 207 controls (61 ± 8.3 years old, 49.5% males). The mean disease duration was 5.5 ± 4.4 years. Hoehn and Yahr stage was 1 or 2 in 90.7% of the patients whilst 33.9% and 18.1% of them presented motor fluctuations and dyskinesias, respectively. The mean Non‐Motor Symptoms Scale total score was 45.4 ± 38.1, and 30.4% of the patients presented cognitive impairment, 16.1% major depression, 12.7% impulse control disorder, 7.2% compulsive behaviour, 57.2% pain and 13.2% falls. Compared to the control group, PD patients presented a significantly higher burden of non‐motor symptoms and a worse quality of life. More than 300 subjects conducted complementary studies (serum biomarkers, genetic and neuroimaging).
[Conclusions]: Parkinson's disease is a complex disorder and different non‐motor symptoms are frequently present and are more prevalent than in controls. In real clinical practice it is important to ask for them.
Versión del editorhttp://dx.doi.org/10.1111/ene.14008
URIhttp://hdl.handle.net/10261/214106
DOI10.1111/ene.14008
ISSN1351-5101
E-ISSN1468-1331
Aparece en las colecciones: (IBIS) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

SCOPUSTM   
Citations

30
checked on 17-mar-2024

WEB OF SCIENCETM
Citations

34
checked on 25-feb-2024

Page view(s)

207
checked on 18-mar-2024

Download(s)

66
checked on 18-mar-2024

Google ScholarTM

Check

Altmetric

Altmetric


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.